Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
NCT01183832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 490
Last updated 2019-05-30
Summary
This study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.
Conditions
Sponsors & Collaborators
-
Centre Oscar Lambret
lead OTHER
Principal Investigators
-
Yazid BELKACEMI, MD, PhD · Centre Oscar Lambret
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2015-01-13
- Completion
- 2016-01-31
Countries
- France
- Monaco
Study Locations
More Related Trials
-
Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole
NCT00623519 ·Status: COMPLETED
-
Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
NCT00629616 ·Status: COMPLETED ·Phase: PHASE2
-
Arthralgia During Anastrozole Therapy for Breast Cancer
NCT00323479 ·Status: COMPLETED ·Phase: PHASE4
-
OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)
NCT02335957 ·Status: COMPLETED ·Phase: NA
-
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
NCT00210028 ·Status: TERMINATED ·Phase: PHASE2
-
Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer
NCT03946579 ·Status: COMPLETED ·Phase: NA
-
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
NCT01151215 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
NCT01553903 ·Status: COMPLETED ·Phase: PHASE4
-
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer
NCT00871858 ·Status: COMPLETED ·Phase: PHASE2
-
Electronic Study for Anastrozole Pharmacovigilance Evaluation
NCT00558168 ·Status: COMPLETED
-
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
NCT03284957 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Patient's Anastrozole Compliance to Therapy Programme
NCT00555867 ·Status: TERMINATED
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED
-
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT00248170 ·Status: COMPLETED ·Phase: PHASE3
-
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)
NCT00126360 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
NCT00235937 ·Status: COMPLETED ·Phase: PHASE2
-
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
NCT04134598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Secondary Adjuvant Long Term Study With Arimidex
NCT00295620 ·Status: COMPLETED ·Phase: PHASE3
-
GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance
NCT02994914 ·Status: TERMINATED ·Phase: NA
-
Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
NCT00681369 ·Status: COMPLETED
-
Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
NCT00688909 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
NCT00256698 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3